Did You Know...
...that after Parker Brothers executives turned down the game of Monopoly because it had "52 fundamental errors" (including taking too long to play), a copy of the game wound up in the home of the company president who stayed up until 1 a.m. to finish playing it? He was so impressed by the game that the next day he wrote to inventor Charles Darrow and offered to buy it!
PatentStorm News
Make the Most of PatentStorm
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest patents by subscribing to an RSS feed.
Got questions? Ask a Patent Expert!
Registered users: Manage your profile, comments and alerts.
US Patent 5208219 - Method for inducing bone growth
US Patent Issued on May 4, 1993
Estimated Patent Expiration Date:
February 14, 2011Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
Estimated Patent Expiration Date:
February 14, 2011Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.AbstractActivin is administered systemically and locally to induce the growth of mature bone. Activin enhances the level of bone formation and the quality of the bone formed when administered locally with BMP or bone marrow. Administration of activin by subcutaneous route promotes systemic increase in the bone mass.Other References
| InventorsAssigneeApplicationNo. 655313 filed on 02/14/1991US Classes:514/12, 25 or more peptide repeating units in known peptide chain structure514/2, Peptide containing (e.g., protein, peptones, fibrinogen, etc.) DOAI514/8, Glycoprotein (carbohydrate containing)514/21, Produced by or extracted from animal tissue530/350, PROTEINS, I.E., MORE THAN 100 AMINO ACID RESIDUES530/397, Glycoprotein hormones530/399, Hormones, e.g., prolactin, thymosin, growth factors, etc.530/416, Ion exchange530/417Chromatography or by septum selective as to material, e.g., gel filtration, molecular sieve dialysis, etc.Field of Search514/2, Peptide containing (e.g., protein, peptones, fibrinogen, etc.) DOAI514/12, 25 or more peptide repeating units in known peptide chain structure514/8, Glycoprotein (carbohydrate containing)514/21, Produced by or extracted from animal tissue530/417, Chromatography or by septum selective as to material, e.g., gel filtration, molecular sieve dialysis, etc.530/416, Ion exchange530/399, Hormones, e.g., prolactin, thymosin, growth factors, etc.530/397, Glycoprotein hormones530/350PROTEINS, I.E., MORE THAN 100 AMINO ACID RESIDUESExaminersPrimary: Moezie, F. T.Attorney, Agent or FirmUS Patent References5071834Purified activin B compositionIssued on: 12/10/1991 Inventor: Burton, et al. International ClassesA61K 037/02A61K 037/36 |
